Dabur India Ltd logo

Dabur India Ltd

DABUR NSE

Key Fundamentals

MidcapPersonal CareConsumer Goods
Market Cap
₹71,588 Cr
Volatility
Moderate
P/E Ratio
36.29
EBITDA
₹3,052 Cr
Return on Equity
15.83%
Debt to Equity
0.11
Book Value
₹64.37
EPS
₹10.6
52W High
₹577
52W Low
₹402.45

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Dabur India Ltd insights

62 extracted metrics + investor summaries across FY13–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

1
  • Company has been maintaining a healthy dividend payout of 70.1%

Weaknesses

1
  • The company has delivered a poor sales growth of 6.65% over past five years.

Growth Rate

Revenue Growth
5.18% ↘
Net Income Growth
7.37% ↘
Cash Flow Change
29.79% ↗
ROE
1.93% ↘
ROCE
3.15% ↘
EBITDA Margin (Avg.)
1.24% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 5d ago
AI opinion · based on fundamentals
Risk medium

Dabur India Ltd is a ₹72,377 Cr market-cap FMCG company trading at a PE of 37.4x. FY2026 consolidated revenue grew 5% to ₹13,193 Cr while net profit grew 7.4% to ₹1,869 Cr, reflecting modest single-digit growth against a backdrop of muted urban demand and competitive pressures from peers delivering higher volume growth.

Bull Case 8
  • Consistent dividend payout of 70.1% with a current dividend yield of 2.01%, providing steady income in a low-growth environment
  • FY2026 net profit grew 7.4% YoY to ₹1,869 Cr, with operating margin improving 15 bps to 18.6%, showing margin resilience
  • Q4 FY2026 net profit surged 16% YoY to ₹362 Cr indicating an acceleration in earnings trajectory in the latest quarter
  • Rural demand outperformed urban markets for eight consecutive quarters with a 330 bps gap, benefiting Dabur's rural-heavy distribution
  • TTM compounded profit growth of 11% marks a meaningful improvement over the 5-year CAGR of just 2%, suggesting earnings recovery
  • 10-year ROE average of 21% and last-year ROE of 17% demonstrate sustained capital efficiency for a consumer staples business
  • Gross margins expanded 33 bps YoY to 48.4% in Q3 FY2026, reflecting benign raw material costs and pricing power in key categories
  • Stock has corrected 18% over one year, compressing valuations from historical peaks and offering a lower entry multiple relative to its own history
Bear Case 8
  • 5-year compounded sales CAGR of only 7% and reported past-5-year sales growth of 6.65% signal structurally sluggish top-line expansion
  • Stock price CAGR is negative across 1-year (-18%), 3-year (-10%), and 5-year (-7%) horizons, indicating sustained value destruction for shareholders
  • Q4 FY2026 volume growth of 6% lagged peers Marico (9%) and Godrej Consumer (8%), reflecting competitive market share pressures
  • PE of 37.4x is expensive relative to a 5-year profit CAGR of only 2%, implying a PEG ratio well above 1x
  • ROE has declined from a 10-year average of 21% to 17% in the last year, pointing to diminishing return on equity
  • FY2025 EBITDA margin contracted to 22.8% from 23.2% in FY2024 before the recent recovery, showing margin volatility
  • 5-year compounded profit CAGR of just 2% lags sector peers and barely keeps pace with inflation
  • EBITDA margin was flat YoY at 15.2% in Q4 FY2026 on a standalone basis, suggesting limited near-term operating leverage

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 18h ago
Headwinds 2
  • US FDA warning on Silvassa plant Aug 6

    FDA issued warning letter dated July 24 citing data integrity issues at Dabur's Silvassa manufacturing plant. Company must correct violations and respond within 15 working days.

  • FSSAI labelling action on products Aug 4

    FSSAI issued order on '100% Pure' food product labelling, though Dabur clarified impact is limited to specific food items. High Court has stayed the ban granting interim relief, matter remains pending.

Positives 4
  • Q1 profit surges 15% to ₹591Cr Jul 29

    Dabur reported Q1 FY27 net profit up 15% to ₹591 crore, consolidated revenue up 10.6% to ₹3,764 crore, and India FMCG business growing 9.5%.

  • ₹5.50 final dividend approved at AGM Aug 6

    Shareholders approved ₹5.50 per share final dividend and reappointed key directors at the 51st AGM held on August 6, 2026.

  • ESG rating upgraded to Strong Jul 30

    Crisil upgraded Dabur India's ESG rating to Strong, citing robust performance on environmental and governance parameters.

  • Double-digit volume growth target FY27 Jul 30

    Dabur targets double-digit sales volume growth with PAT outpacing revenue by FY27. Allocated ₹500 crore to Dabur Ventures for D2C acquisitions and reported 18% hair oil value growth in Q1.

Neutral 3
  • Active acquisition talks with 2-3 firms Jul 29

    Dabur executive confirmed discussions with 2-3 firms for possible acquisitions, though no deal value, target identity, or timelines disclosed.

  • Herjit S. Bhalla appointed CEO Jul 29

    Dabur appointed Herjit S. Bhalla as CEO for India Business effective April 23, 2026, following board-approved internal restructuring on July 29.

  • GST audit penalty of ₹25.39 lakh settled Aug 4

    Dabur paid ₹25.39 lakh penalty to close GST audit proceedings for FY21-FY24 related to ineligible ITC issues in Ghaziabad.

TL;DR: Dabur delivered a strong Q1 FY27 with 15% profit growth and 10.6% revenue expansion, supported by healthy volume trends and an upgraded ESG rating. Key risks include a US FDA warning letter on its Silvassa plant requiring corrective action and FSSAI regulatory scrutiny on product labelling, though the latter has been stayed by the High Court. The company's forward guidance of double-digit volume growth, ₹500 crore D2C acquisition fund, and active M&A discussions signal confidence in medium-term momentum, provided regulatory issues are resolved without material disruption.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
3,130
3,204
3,255
2,815
3,349
3,029
3,355
2,830
3,405
3,191
3,559
3,038
3,764
Expenses
2,526
2,543
2,588
2,348
2,694
2,476
2,673
2,403
2,737
2,603
2,825
2,577
3,024
Operating Profit
605
661
667
466
655
553
682
427
667
588
734
461
741
OPM %
19%
21%
20%
17%
20%
18%
20%
15%
20%
18%
21%
15%
20%
Other Income
110
117
127
129
129
152
129
141
144
140
126
175
173
Interest
24
28
36
35
33
47
44
39
35
40
31
40
37
Depreciation
97
98
97
107
109
111
109
117
114
115
117
122
121
PBT
593
651
661
453
642
546
658
412
663
573
711
474
756
Tax %
23%
22%
23%
25%
23%
24%
22%
24%
23%
22%
22%
24%
22%
Net Profit
457
507
506
341
494
418
516
313
508
445
554
362
586
EPS in Rs
2.62
2.91
2.9
1.97
2.82
2.4
2.95
1.81
2.9
2.55
3.16
2.08
3.33
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
7,795
7,780
7,614
7,722
8,515
8,685
9,562
10,889
11,530
12,404
12,563
13,193
13,552
Expenses
6,475
6,261
6,102
6,104
6,775
6,892
7,560
8,637
9,367
10,004
10,247
10,743
11,029
Operating Profit
1,320
1,518
1,512
1,617
1,740
1,792
2,002
2,252
2,162
2,400
2,316
2,450
2,524
OPM %
17%
20%
20%
21%
20%
21%
21%
21%
19%
19%
18%
19%
19%
Other Income
154
217
296
291
222
205
325
308
445
482
551
585
613
Interest
40
48
54
53
60
50
31
39
78
124
164
145
147
Depreciation
115
133
143
162
177
220
240
253
311
399
446
469
476
PBT
1,319
1,554
1,611
1,693
1,725
1,728
2,056
2,269
2,219
2,359
2,258
2,420
2,513
Tax %
19%
19%
21%
20%
16%
16%
18%
23%
23%
23%
23%
23%
—
Net Profit
1,068
1,254
1,280
1,358
1,446
1,448
1,695
1,742
1,701
1,811
1,740
1,869
1,947
EPS in Rs
6.07
7.11
7.25
7.69
8.17
8.18
9.58
9.84
9.64
10.4
9.97
10.68
11.12
Div. Payout %
33%
32%
31%
81%
34%
37%
50%
53%
54%
53%
80%
77%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
176
176
176
176
177
177
177
177
177
177
177
177
Reserves
3,178
3,995
4,671
5,530
5,455
6,429
7,487
8,205
8,796
9,689
10,623
11,242
Borrowings
734
805
975
938
699
522
509
1,030
1,174
1,365
950
1,287
Other Liabilities
2,019
1,956
1,910
2,058
2,106
2,209
2,661
2,872
3,505
3,885
4,479
4,773
Total Liabilities
6,106
6,932
7,732
8,702
8,437
9,337
10,833
12,284
13,652
15,116
16,230
17,480
Fixed Assets
1,877
1,667
1,958
2,028
1,969
2,253
2,243
2,308
3,579
3,815
3,990
3,938
CWIP
50
45
42
42
64
147
147
168
175
232
169
139
Investments
1,813
2,691
3,240
3,805
3,359
2,800
4,160
6,220
6,265
6,933
7,468
8,947
Other Assets
2,365
2,529
2,492
2,827
3,045
4,137
4,283
3,589
3,633
4,136
4,603
4,456
Total Assets
6,106
6,932
7,732
8,702
8,437
9,337
10,833
12,284
13,652
15,116
16,230
17,480
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1,047
1,187
1,227
1,092
1,499
1,614
2,115
1,802
1,488
2,013
1,987
2,579
Investing
-876
-730
-807
-541
338
-517
-1,404
-1,273
-583
-971
-448
-1,279
Financing
-417
-374
-339
-577
-1,888
-1,043
-613
-490
-1,035
-1,161
-1,405
-1,236
Net Cash Flow
-245
82
81
-27
-51
54
97
38
-130
-119
133
64
Free Cash Flow
796
998
741
891
1,274
1,213
1,808
1,433
1,003
1,453
1,448
2,180
CFO/OP
97
97
102
88
106
107
122
97
92
104
103
122
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
33
38
31
33
36
34
21
22
27
26
26
20
Inventory Days
136
150
153
169
154
164
178
169
158
149
175
166
Days Payable
153
182
181
190
172
176
197
178
171
186
215
212
Cash Conversion Cycle
16
6
3
13
17
22
3
12
14
-10
-14
-26
Working Capital Days
-17
0
-7
-1
-5
9
-9
-14
-13
-17
-13
-42
ROCE %
36%
35%
31%
28%
28%
28%
27%
27%
23%
22%
20%
20%

Shareholding Pattern

As of Jun 2026
Promoters 66.24%
DIIs 18.72%
FIIs 9.66%
Public 4.28%
Others 1.09%
Total 99.99%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
67.38%
67.36%
67.36%
67.37%
67.38%
67.24%
67.24%
66.24%
66.24%
66.23%
66.23%
66.24%
66.25%
66.24%
66.25%
66.26%
66.27%
66.22%
66.22%
66.23%
66.25%
66.24%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
15.83%
14.98%
15.04%
13.27%
12.68%
11.85%
10.89%
10.05%
9.98%
9.66%
DIIs
5.28%
4.61%
3.36%
3.51%
3.78%
3.98%
5.77%
7.61%
8.43%
8.87%
8.61%
10.35%
12.56%
13.56%
13.67%
14.92%
15.69%
16.24%
17.39%
18.38%
18.56%
18.72%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
5.43%
5.29%
5.28%
5.55%
5.28%
5.18%
4.47%
4.34%
4.32%
4.29%
4.26%
4.28%
4.19%
4.03%
3.92%
4.34%
4.19%
4.44%
4.18%
4.21%
4.13%
4.28%
Others
21.91%
22.74%
23.99%
23.57%
23.56%
23.61%
22.53%
21.82%
21.00%
20.61%
20.90%
19.13%
1.17%
1.18%
1.12%
1.20%
1.17%
1.25%
1.32%
1.13%
1.09%
1.09%
No. of Shareholders
2,96,439
3,18,852
3,59,529
4,33,443
4,82,133
4,83,560
4,57,490
4,43,618
4,48,975
4,44,832
4,33,501
4,39,123
4,34,823
4,35,213
4,30,436
5,10,298
5,05,557
5,20,024
4,97,123
4,84,326
4,69,624
4,79,265

Documents

Frequently Asked Questions about Dabur India Ltd

What does Dabur India Ltd do?
Dabur is India’s leading FMCG, Ayurvedic and natural health care company with wide network distribution across world. [1]
Where is Dabur India Ltd (DABUR) listed?
Dabur India Ltd is listed on the Indian stock exchanges. It is listed on NSE: DABUR and BSE: 500096. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Dabur India Ltd belong to?
Dabur India Ltd operates in the Consumer Goods sector within the Personal Care industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Dabur India Ltd?
Dabur India Ltd has a market capitalisation of approximately ₹71587.85 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Dabur India Ltd?
The Price-to-Earnings (PE) ratio of Dabur India Ltd is 36.29. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Dabur India Ltd?
Over the past 52 weeks, Dabur India Ltd has traded between a low of ₹402.45 and a high of ₹577. This range helps investors understand the stock's price volatility and recent trading levels.
Does Dabur India Ltd pay dividends?
Yes, Dabur India Ltd has a dividend yield of 2.03%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Dabur India Ltd?
Dabur India Ltd has a Return on Equity (ROE) of 15.83%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Dabur India Ltd on Tapetide?
On Tapetide, you can view Dabur India Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Dabur is India’s leading FMCG, Ayurvedic and natural health care company with wide network distribution across world. [1]

Website dabur.com
CEO Mr. Mohit Malhotra M.B.A.
Employees 5,341
Listed 1999-04-28
Face Value ₹ 1
Issued Size 1,77,36,90,172

Explore More

More in Consumer Goods → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List